Affinia Therapeutics an innovative gene therapy company with a pipeline of rationally designed adeno-associated virus (AAV) gene therapies for devastating cardiovascular and neurological diseases,...
Zafrens, a pioneering biotech company transforming drug discovery, welcomes imec.xpand to its Series A syndicate, bringing the total capital raised to USD 31 million. imec.xpand...
Boundless Bio a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, announced...
TriLink BioTechnologies, a Maravai LifeSciences company and global provider of reagents and services to the life sciences, has partnered with Avantor a global leader in...
Averna Therapeutics a biotechnology company developing genomic medicines that insert therapeutic changes into the genome, announced the appointment of Thomas M. Barnes, Ph.D., as...
